111 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
In the Company’s ongoing patent infringement lawsuit against Mylan Pharmaceuticals Inc., a wholly-owned subsidiary of Viatris Inc., and Biocon Biologics
DEFA14A
yw78vjkjz7 1axg0y4g9
21 Apr 22
Additional proxy soliciting materials
4:21pm
424B5
jsc92z0btfxvylz
10 Aug 20
Prospectus supplement for primary offering
9:37pm
424B3
36dkcfjs77vp9ukp
7 Aug 20
Prospectus supplement
9:27am